(Duke University Medical Center) The push to develop treatments for Alzheimer's disease has yielded a greater understanding of the disease, but has failed to generate successful new drugs.To blame are the many undefined subtypes of mild cognitive impairment, a precursor to Alzheimer's disease. But if scientists grouped people with similar types of cognitive impairment, they could more precisely test the impact of investigational drugs, according to findings in a July 28 article in the journal Scientific Reports, a publication of Nature Research.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2h8vJkg
No comments:
Post a Comment